Skip to main content
PharmAbcine Inc. logo

PharmAbcine Inc. — Investor Relations & Filings

Ticker · 208340 ISIN · KR7208340000 KO Manufacturing
Filings indexed 461 across all filing types
Latest filing 2026-04-07 Audit Report / Informat…
Country KR South Korea
Listing KO 208340

About PharmAbcine Inc.

http://pharmabcine.com/

PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.

Recent filings

Filing Released Lang Actions
사업보고서 (2025.12)
Audit Report / Information Classification · 95% confidence The document is titled “연결감사보고서” and contains an independent auditor’s report (한정의견), detailed auditor’s responsibilities, emphasis-of-matter paragraphs, and the audited consolidated financial statements with notes. It is not an annual report or earnings release but a standalone audit report. Therefore, it fits the definition of an Audit Report / Information (AR). FY 2025
2026-04-07 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 75% confidence The document is a corrected notice (“정정공고”) convening a shareholders’ meeting (“주주총회소집공고”) for Pamipshin, complete with proposed agenda items and full financial statements. It is not simply an announcement with a link, but the actual meeting materials sent to shareholders to solicit votes on proposals. This aligns with a Proxy Solicitation & Information Statement (PSI) rather than an annual report, earnings release, or AGM presentation. Therefore, the correct classification is PSI.
2026-04-02 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 87% confidence The document is a “주주총회소집공고” (Notice of Convening a General Meeting of Shareholders) that includes the formal meeting notice (date, place, agenda items) and detailed background information (management reference matters, business overview, director activities, etc.) provided to shareholders ahead of the meeting to solicit their votes. This matches the definition of Proxy Solicitation & Information Statement (PSI) – materials sent to shareholders to provide meeting information and request votes, rather than the full annual report or post‐meeting voting results.
2026-04-01 Korean
[기재정정]사업보고서 (2024.12)
Audit Report / Information Classification · 95% confidence The document is a standalone, detailed auditor’s report (“감사보고서”) including the independent auditor’s opinion, emphasis of matter, key audit matters, full financial statements (balance sheet, income statement, cash flows, notes), and details of audit procedures. It is not an announcement or summary but the actual audit report itself. Therefore, it fits the Audit Report / Information category (Code: AR). FY 2024
2026-03-31 Korean
사업보고서제출기한연장신고서 (2025.12)
Regulatory Filings Classification · 85% confidence The document is a notification to the financial regulator and stock exchange regarding an extension of the submission deadline for the company’s annual business report and audit report. It is not the actual annual report or audit report itself, but rather a regulatory filing notifying of a deadline extension. No specific category covers deadline extension notices, so it falls into the fallback “Regulatory Filings” category (RNS).
2026-03-23 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results from an Extraordinary General Meeting (EGM) of shareholders for the company 'Pabio'. It details the resolutions passed, including the appointment of directors (both executive and outside) and amendments to the articles of incorporation. This falls under the category of Declaration of Voting Results & Voting Rights Announcements, as it confirms the outcome of shareholder votes.
2026-01-15 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.